Last reviewed · How we verify
NCT05510778
Effects of CharcoCaps® (Activated Charcoal) vs. Placebo on Intestinal Gas Production
NA trial testing Charcocaps in Intestinal Gas in 20 participants. Completed in 22 December 2021.
22 December 2021
Quick facts
| Lead sponsor | University of Memphis |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 30 September 2021 |
| Primary completion | 22 December 2021 |
| Estimated completion | 22 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Charcocaps
- Placebo
Conditions studied
- Intestinal Gas — all drugs for Intestinal Gas →
Sponsor
University of Memphis
Who can join
Adults 18 to 65, any sex, with Intestinal Gas. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Consumption of a high-fiber diet, often consisting of beans and vegetables, is recommended for improvements in overall health. Unfortunately, intake of the above-mentioned foods is often associated with a significant increase in intestinal gas production. In addition to gas, abdominal bloating, cramping, and associated symptoms can prove unacceptable-leading people to limit or abandon the consumption of bean-rich meals. In an attempt to reduce gas formation and the ensuing symptoms, various anti-gas products have been developed and are sold on the market. One such non-prescription product is Beano, a solution of the enzyme alpha-galactosidase. In addition to alpha-galactosidase, activated charcoal has also been used successfully in some, but not all, studies and may be a good option for certain individuals. CharcoCaps® is a branded form of activated charcoal that has been sold for several years.That said, no controlled studies have been conducted using CharcoCaps®. This study will investigate the effects of ingesting CharcoCaps® before and following the meal on the amount of gas produced, the number of flatus events, and associated symptoms of GI distress during the 6-hour post meal ingestion period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05510778
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Memphis trials
Trials by the same sponsor.
- NCT07507344 — Beverage Hydration Index of Different Solutions · NA · recruiting
- NCT07215351 — Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women · NA · recruiting
- NCT06733532 — Comparison of the Beverage Hydration Index of Different Solutions · NA · completed
- NCT06318962 — Examining the Efficacy of a Digital Therapeutic to Prevent Suicidal Behaviors · NA · recruiting
- NCT06272435 — Beverage Hydration Index: Assessment of Four Rehydration Solutions · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05510778 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Memphis
- Last refreshed: 22 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05510778.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing